{"transactions":[{"id":702060,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-29T00:25:04.000Z","date":"2026-07-26","kind":"grant","planned":false,"acquired":true,"shares":62221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025."}],"balance_after":67470,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":62221},"source":{"system":"sec-edgar","filing":"0000897069-26-001552","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706926001552/form4.xml","form_type":"4"}},{"id":722619,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2026-06-30T20:47:07.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":false,"shares":203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of time-based service award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of time-based service award."}],"balance_after":5249,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":203},"source":{"system":"sec-edgar","filing":"0000897069-26-001468","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706926001468/form4.xml","form_type":"4"}},{"id":722618,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-30T20:47:07.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":true,"shares":203,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of time-based service award."}],"balance_after":1021,"source":{"system":"sec-edgar","filing":"0000897069-26-001468","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706926001468/form4.xml","form_type":"4"}},{"id":819029,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T21:12:17.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":789,"price":2.535,"value":2000.115,"ownership":{"direct":true},"balance_after":818,"source":{"system":"sec-edgar","filing":"0000897069-26-000781","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706926000781/form4.xml","form_type":"4"}},{"id":841229,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrants to purchase ADRs","published_at":"2026-03-16T21:00:03.000Z","date":"2025-12-16","kind":"purchase","planned":false,"acquired":true,"shares":3093,"price":0.4041,"value":1249.8813,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer."},{"field":"security","element":"securityTitle","label":"F5","text":"On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the \"Note Exchange Unregistered Pre-Funded Warrants\") to purchase up to 3,093 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 3,219 ADSs (the \"Note Exchange Unregistered Warrants\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Conversion Exercise Price of Security is $0.00001"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the \"Note Exchange Unregistered Pre-Funded Warrants\") to purchase up to 3,093 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 3,219 ADSs (the \"Note Exchange Unregistered Warrants\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised."}],"balance_after":3093,"derivative":{"exercise_price":0,"underlying":"American Depositary Shares representing Ordinary Shares","underlying_shares":3093},"source":{"system":"sec-edgar","filing":"0001493152-26-010304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1541157/000149315226010304/ownership.xml","form_type":"4"}},{"id":841228,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants to purchase ADRs","published_at":"2026-03-16T21:00:03.000Z","date":"2025-12-16","kind":"purchase","planned":false,"acquired":true,"shares":3093,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer."},{"field":"security","element":"securityTitle","label":"F5","text":"On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the \"Note Exchange Unregistered Pre-Funded Warrants\") to purchase up to 3,093 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 3,219 ADSs (the \"Note Exchange Unregistered Warrants\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the \"Note Exchange Unregistered Pre-Funded Warrants\") to purchase up to 3,093 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 3,219 ADSs (the \"Note Exchange Unregistered Warrants\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Note Exchange Unregistered Warrants and the Note Exchange Unregistered Pre-Funded Warrants shall be exercisable upon shareholder approval, with the Note Exchange Unregistered Warrants having a five-year term from such approval, and the Note Exchange Unregistered Pre-Funded Warrants remaining exercisable until fully exercised."}],"balance_after":3093,"derivative":{"exercise_price":0.3883,"underlying":"American Depositary Shares representing Ordinary Shares","underlying_shares":3093},"source":{"system":"sec-edgar","filing":"0001493152-26-010304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1541157/000149315226010304/ownership.xml","form_type":"4"}},{"id":841227,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrants to purchase ADRs","published_at":"2026-03-16T21:00:03.000Z","date":"2025-12-16","kind":"purchase","planned":false,"acquired":true,"shares":2473,"price":0.4041,"value":999.3393,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer."},{"field":"security","element":"securityTitle","label":"F2","text":"On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 2,473 ADSs (the \"PIPE PFWs\" and ) and (ii) accompanying Series G Warrants to purchase up to 2,473 ADSs (the \"Series G Warrants\"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Conversion Exercise Price of Security is $0.00001"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised."}],"balance_after":2473,"derivative":{"exercise_price":0,"underlying":"American Depositary Shares representing Ordinary Shares","underlying_shares":2473},"source":{"system":"sec-edgar","filing":"0001493152-26-010304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1541157/000149315226010304/ownership.xml","form_type":"4"}},{"id":841226,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants to purchase American Depositary Shares (\"ADRs\")","published_at":"2026-03-16T21:00:03.000Z","date":"2025-12-16","kind":"purchase","planned":false,"acquired":true,"shares":2473,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.000000005 per Ordinary Share of the Issuer."},{"field":"security","element":"securityTitle","label":"F2","text":"On December 16, 2025, the Reporting Person acquired (i) unregistered pre-funded warrants to purchase up to 2,473 ADSs (the \"PIPE PFWs\" and ) and (ii) accompanying Series G Warrants to purchase up to 2,473 ADSs (the \"Series G Warrants\"), at a combined purchase price of $0.4041 per PIPE PFW and Series G Warrant in a private placement transaction pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series G Warrants and the PIPE PFWs shall be exercisable upon shareholder approval, with the Series G Warrants having a five-year term from such approval, and the PIPE PFWs remaining exercisable until fully exercised."}],"balance_after":2473,"derivative":{"exercise_price":0.3883,"underlying":"American Depositary Shares representing Ordinary Shares","underlying_shares":2473},"source":{"system":"sec-edgar","filing":"0001493152-26-010304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1541157/000149315226010304/ownership.xml","form_type":"4"}},{"id":1024131,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:41:27.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":300000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000897069-25-001561","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706925001561/form4.xml","form_type":"4"}},{"id":1024130,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:41:27.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":100000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000897069-25-001561","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706925001561/form4.xml","form_type":"4"}},{"id":1036141,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true}}],"security":"Restricted Stock","published_at":"2025-09-18T20:19:51.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":31206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amending to correct the beneficially owned shares reported on the Form 4 filed September 18, 2024."}],"balance_after":36275,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":31206},"source":{"system":"sec-edgar","filing":"0000897069-25-001496","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706925001496/form4.xml","form_type":"4/A","original_submission_date":"2025-07-28"}},{"id":1080500,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true}}],"security":"Restricted Stock","published_at":"2025-07-28T20:21:29.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":175299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan (\"Omnibus Plan\"), of which 125,999 shares are subject to stockholder approval of the revised Omnibus Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock vest on the earlier of June 30, 2026 or the next annual meeting of stockholders, subject to certain distribution requirements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock vest on the earlier of June 30, 2026 or the next annual meeting of stockholders, subject to certain distribution requirements."}],"balance_after":206505,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":175299},"source":{"system":"sec-edgar","filing":"0000897069-25-001211","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706925001211/form4.xml","form_type":"4"}},{"id":1193162,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-24T21:00:16.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. Subject to the Reporting Person's continued service with the Issuer and shareholder approval covering the issuance of the ADS underlying this stock option, this option shall vest (i) 25% on the grant date (ii) 25% on December 31, 2025 and (iii) the remaining 50% shall vest ratably on a monthly basis over the 24 month period thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer."}],"balance_after":225000,"derivative":{"exercise_price":1.5,"expiration_date":"2035-03-20","underlying":"American Depositary Shares representing Ordinary Shares","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000950170-25-043940","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1541157/000095017025043940/ownership.xml","form_type":"4"}},{"id":1193161,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-24T21:00:16.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer."}],"balance_after":175000,"derivative":{"exercise_price":1.5,"expiration_date":"2035-03-20","underlying":"American Depositary Shares representing Ordinary Shares","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0000950170-25-043940","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1541157/000095017025043940/ownership.xml","form_type":"4"}},{"id":1214566,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrants (Right to Buy)","published_at":"2025-03-10T21:00:09.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":4464,"price":1.12,"value":4999.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On March 6, 2025, the Reporting Person acquired 4,464 ADS  and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025.  The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 6, 2025, the Reporting Person acquired 4,464 ADS  and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025.  The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer."}],"balance_after":4464,"derivative":{"exercise_price":0.87,"exercise_date":"2025-03-06","expiration_date":"2030-03-06","underlying":"American Depositary Shares representing Ordinary Shares","underlying_shares":4464},"source":{"system":"sec-edgar","filing":"0000950170-25-036485","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1541157/000095017025036485/ownership.xml","form_type":"4"}},{"id":1214565,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrants (Right to Buy)","published_at":"2025-03-10T21:00:09.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":4464,"price":1.12,"value":4999.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On March 6, 2025, the Reporting Person acquired 4,464 ADS  and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025.  The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 6, 2025, the Reporting Person acquired 4,464 ADS  and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025.  The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer."}],"balance_after":4464,"derivative":{"exercise_price":0.87,"exercise_date":"2025-03-06","expiration_date":"2026-03-06","underlying":"American Depositary Shares representing Ordinary Shares","underlying_shares":4464},"source":{"system":"sec-edgar","filing":"0000950170-25-036485","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1541157/000095017025036485/ownership.xml","form_type":"4"}},{"id":1214564,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares representing Ordinary Shares","published_at":"2025-03-10T21:00:09.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":4464,"price":1.12,"value":4999.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share (\"ADS\") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On March 6, 2025, the Reporting Person acquired 4,464 ADS  and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025.  The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 6, 2025, the Reporting Person acquired 4,464 ADS  and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025.  The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant."}],"balance_after":36271,"source":{"system":"sec-edgar","filing":"0000950170-25-036485","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1541157/000095017025036485/ownership.xml","form_type":"4"}},{"id":1304933,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001 per share","published_at":"2025-01-10T22:30:04.000Z","date":"2025-01-09","kind":"grant","planned":false,"acquired":true,"shares":8000000,"price":0.0006,"value":4800.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On January 9, 2025, the Reporting Person acquired 8,000,000 Ordinary Shares at a purchase price of $0.00065 per Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 9, 2025, the Reporting Person acquired 8,000,000 Ordinary Shares at a purchase price of $0.00065 per Ordinary Share."}],"balance_after":32216000,"source":{"system":"sec-edgar","filing":"0000950170-25-004300","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1541157/000095017025004300/ownership.xml","form_type":"4"}},{"id":1321501,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001 per share","published_at":"2024-12-26T21:30:06.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":2000000,"price":0.0005,"value":1000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents 2,000 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 23, 2024, the Reporting Person acquired 2,000,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 23, 2024, the Reporting Person acquired 2,000,000 Ordinary Shares at a purchase price of $0.0005 per Ordinary Share."}],"balance_after":24216000,"source":{"system":"sec-edgar","filing":"0000950170-24-140431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1541157/000095017024140431/ownership.xml","form_type":"4"}},{"id":1361346,"issuer":{"id":85431,"kind":"organization","name":"Peak Bio, Inc.","symbol":"PKBO"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-18T23:54:03.000Z","date":"2024-11-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the terms of the Agreement and Plan of Merger, dated as of March 4, 2024, as amended (the \"Merger Agreement\"), by and among the Issuer, Akari Therapeutics Plc (\"Parent\"), and Pegasus Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer effective as of November 14, 2024, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F5","text":"At the Effective Time, each option to purchase shares of Peak Common Stock (\"Peak Option\") that was outstanding immediately prior to the Effective Time and unexercised, whether or not vested, was assumed by Parent and converted into the option to purchase a number of Ordinary Shares or ADSs (any such option, an \"Assumed Option\") equal to the number of Peak Common Stock underlying each such Peak Option multiplied by the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"At the Effective Time, each option to purchase shares of Peak Common Stock (\"Peak Option\") that was outstanding immediately prior to the Effective Time and unexercised, whether or not vested, was assumed by Parent and converted into the option to purchase a number of Ordinary Shares or ADSs (any such option, an \"Assumed Option\") equal to the number of Peak Common Stock underlying each such Peak Option multiplied by the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"At the Effective Time, each option to purchase shares of Peak Common Stock (\"Peak Option\") that was outstanding immediately prior to the Effective Time and unexercised, whether or not vested, was assumed by Parent and converted into the option to purchase a number of Ordinary Shares or ADSs (any such option, an \"Assumed Option\") equal to the number of Peak Common Stock underlying each such Peak Option multiplied by the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":0.8,"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000950170-24-128150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1600865/000095017024128150/ownership.xml","form_type":"4"}},{"id":1361345,"issuer":{"id":85431,"kind":"organization","name":"Peak Bio, Inc.","symbol":"PKBO"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Purchase)","published_at":"2024-11-18T23:54:03.000Z","date":"2024-11-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":33340,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the terms of the Agreement and Plan of Merger, dated as of March 4, 2024, as amended (the \"Merger Agreement\"), by and among the Issuer, Akari Therapeutics Plc (\"Parent\"), and Pegasus Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer effective as of November 14, 2024, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F4","text":"At the Effective Time, each warrant to purchase capital stock of the Issuer (each, a \"Peak Warrant\") outstanding immediately prior to the Effective Time was converted into warrants to purchase a number of Ordinary Shares or ADSs (the \"Assumed Warrants\"), exercisable for a number of ADSs equal to the number of shares of Peak Common Stock underlying such Peak Warrant multiplied by the Exchange Ratio, and the exercise price with respect to such Assumed Warrants shall be equal to the exercise price of such Peak Warrant divided by the Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each warrant to purchase capital stock of the Issuer (each, a \"Peak Warrant\") outstanding immediately prior to the Effective Time was converted into warrants to purchase a number of Ordinary Shares or ADSs (the \"Assumed Warrants\"), exercisable for a number of ADSs equal to the number of shares of Peak Common Stock underlying such Peak Warrant multiplied by the Exchange Ratio, and the exercise price with respect to such Assumed Warrants shall be equal to the exercise price of such Peak Warrant divided by the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each warrant to purchase capital stock of the Issuer (each, a \"Peak Warrant\") outstanding immediately prior to the Effective Time was converted into warrants to purchase a number of Ordinary Shares or ADSs (the \"Assumed Warrants\"), exercisable for a number of ADSs equal to the number of shares of Peak Common Stock underlying such Peak Warrant multiplied by the Exchange Ratio, and the exercise price with respect to such Assumed Warrants shall be equal to the exercise price of such Peak Warrant divided by the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each warrant to purchase capital stock of the Issuer (each, a \"Peak Warrant\") outstanding immediately prior to the Effective Time was converted into warrants to purchase a number of Ordinary Shares or ADSs (the \"Assumed Warrants\"), exercisable for a number of ADSs equal to the number of shares of Peak Common Stock underlying such Peak Warrant multiplied by the Exchange Ratio, and the exercise price with respect to such Assumed Warrants shall be equal to the exercise price of such Peak Warrant divided by the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":0.6,"underlying":"Common Stock","underlying_shares":33340},"source":{"system":"sec-edgar","filing":"0000950170-24-128150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1600865/000095017024128150/ownership.xml","form_type":"4"}},{"id":1361344,"issuer":{"id":85431,"kind":"organization","name":"Peak Bio, Inc.","symbol":"PKBO"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Notes","published_at":"2024-11-18T23:54:03.000Z","date":"2024-11-14","kind":"exercise","planned":false,"acquired":false,"reported_value":20004,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Immediately prior to the effective time of the Merger (the \"Effective Time\"), the principal amount of convertible promissory notes held by the Reporting Person (together with accrued interest thereon) automatically converted into shares of common stock of the Issuer (\"Peak Common Stock\")."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the terms of the Agreement and Plan of Merger, dated as of March 4, 2024, as amended (the \"Merger Agreement\"), by and among the Issuer, Akari Therapeutics Plc (\"Parent\"), and Pegasus Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer effective as of November 14, 2024, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Immediately prior to the effective time of the Merger (the \"Effective Time\"), the principal amount of convertible promissory notes held by the Reporting Person (together with accrued interest thereon) automatically converted into shares of common stock of the Issuer (\"Peak Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Immediately prior to the effective time of the Merger (the \"Effective Time\"), the principal amount of convertible promissory notes held by the Reporting Person (together with accrued interest thereon) automatically converted into shares of common stock of the Issuer (\"Peak Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately prior to the effective time of the Merger (the \"Effective Time\"), the principal amount of convertible promissory notes held by the Reporting Person (together with accrued interest thereon) automatically converted into shares of common stock of the Issuer (\"Peak Common Stock\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Immediately prior to the effective time of the Merger (the \"Effective Time\"), the principal amount of convertible promissory notes held by the Reporting Person (together with accrued interest thereon) automatically converted into shares of common stock of the Issuer (\"Peak Common Stock\")."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37850},"source":{"system":"sec-edgar","filing":"0000950170-24-128150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600865/000095017024128150/ownership.xml","form_type":"4"}},{"id":1361343,"issuer":{"id":85431,"kind":"organization","name":"Peak Bio, Inc.","symbol":"PKBO"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-18T23:54:03.000Z","date":"2024-11-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":37850,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the terms of the Agreement and Plan of Merger, dated as of March 4, 2024, as amended (the \"Merger Agreement\"), by and among the Issuer, Akari Therapeutics Plc (\"Parent\"), and Pegasus Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer effective as of November 14, 2024, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F3","text":"At the Effective Time, each issued and outstanding share of Peak Common Stock was cancelled and converted into the right to receive 0.2935 (the \"Exchange Ratio\") American Depositary Shares (\"ADSs\") of Parent, each ADS representing a number of ordinary shares, par value $0.0001 per share (the \"Ordinary Shares\") of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each issued and outstanding share of Peak Common Stock was cancelled and converted into the right to receive 0.2935 (the \"Exchange Ratio\") American Depositary Shares (\"ADSs\") of Parent, each ADS representing a number of ordinary shares, par value $0.0001 per share (the \"Ordinary Shares\") of Parent."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-128150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600865/000095017024128150/ownership.xml","form_type":"4"}},{"id":1361342,"issuer":{"id":85431,"kind":"organization","name":"Peak Bio, Inc.","symbol":"PKBO"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-18T23:54:03.000Z","date":"2024-11-14","kind":"exercise","planned":false,"acquired":true,"shares":37850,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the terms of the Agreement and Plan of Merger, dated as of March 4, 2024, as amended (the \"Merger Agreement\"), by and among the Issuer, Akari Therapeutics Plc (\"Parent\"), and Pegasus Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer effective as of November 14, 2024, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Immediately prior to the effective time of the Merger (the \"Effective Time\"), the principal amount of convertible promissory notes held by the Reporting Person (together with accrued interest thereon) automatically converted into shares of common stock of the Issuer (\"Peak Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Immediately prior to the effective time of the Merger (the \"Effective Time\"), the principal amount of convertible promissory notes held by the Reporting Person (together with accrued interest thereon) automatically converted into shares of common stock of the Issuer (\"Peak Common Stock\")."}],"balance_after":37850,"source":{"system":"sec-edgar","filing":"0000950170-24-128150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600865/000095017024128150/ownership.xml","form_type":"4"}},{"id":1403262,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true}}],"security":"Restricted Stock","published_at":"2024-09-18T20:48:42.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":31206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements."}],"balance_after":31206,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":31206},"source":{"system":"sec-edgar","filing":"0000897069-24-001862","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706924001862/form4.xml","form_type":"4"}},{"id":1645868,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-02-13T20:08:49.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":6880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F8","text":"Represents the modification of the option granted on November 21, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":6880,"derivative":{"exercise_price":0.59,"exercise_date":"2023-11-21","expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":6880},"source":{"system":"sec-edgar","filing":"0001493152-24-006049","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006049/ownership.xml","form_type":"4"}},{"id":1645867,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-02-13T20:08:49.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":6880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F8","text":"Represents the modification of the option granted on November 21, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":0.59,"exercise_date":"2023-11-21","expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":6880},"source":{"system":"sec-edgar","filing":"0001493152-24-006049","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006049/ownership.xml","form_type":"4"}},{"id":1645866,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-02-13T20:08:49.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":12160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F7","text":"Represents the modification of the option granted on June 11, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":12160,"derivative":{"exercise_price":1.6,"exercise_date":"2023-06-11","expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":12160},"source":{"system":"sec-edgar","filing":"0001493152-24-006049","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006049/ownership.xml","form_type":"4"}},{"id":1645865,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-02-13T20:08:49.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":12160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F7","text":"Represents the modification of the option granted on June 11, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":1.6,"exercise_date":"2023-06-11","expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":12160},"source":{"system":"sec-edgar","filing":"0001493152-24-006049","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006049/ownership.xml","form_type":"4"}},{"id":1645864,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-13T20:08:49.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This restricted stock unit was granted on November 21, 2023 and pursuant to the issuance upon full vesting described in Footnote 2, is no longer outstanding."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This restricted stock unit was granted on November 21, 2023 and pursuant to the issuance upon full vesting described in Footnote 2, is no longer outstanding."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5820},"source":{"system":"sec-edgar","filing":"0001493152-24-006049","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006049/ownership.xml","form_type":"4"}},{"id":1645863,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-13T20:08:49.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"This restricted stock unit was granted on June 11, 2023 and pursuant to the issuance upon full vesting as described in Footnote 1, is no longer outstanding."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This restricted stock unit was granted on June 11, 2023 and pursuant to the issuance upon full vesting as described in Footnote 1, is no longer outstanding."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5100},"source":{"system":"sec-edgar","filing":"0001493152-24-006049","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006049/ownership.xml","form_type":"4"}},{"id":1645862,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-13T20:08:49.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on June 11, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on November 21, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":10920,"source":{"system":"sec-edgar","filing":"0001493152-24-006049","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006049/ownership.xml","form_type":"4"}},{"id":1645861,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-13T20:08:49.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on June 11, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on June 11, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":5100,"source":{"system":"sec-edgar","filing":"0001493152-24-006049","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224006049/ownership.xml","form_type":"4"}},{"id":1730214,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2023-11-24T21:00:12.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":6880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F5","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."}],"balance_after":6880,"derivative":{"exercise_price":0.59,"expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":6880},"source":{"system":"sec-edgar","filing":"0001493152-23-042662","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223042662/ownership.xml","form_type":"4"}},{"id":1730213,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-11-24T21:00:12.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"N/A."}],"balance_after":5820,"derivative":{"underlying":"Common Stock","underlying_shares":5820},"source":{"system":"sec-edgar","filing":"0001493152-23-042662","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223042662/ownership.xml","form_type":"4"}},{"id":1824039,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true}}],"security":"Restricted Stock","published_at":"2023-07-24T22:38:48.000Z","date":"2023-06-27","kind":"grant","planned":false,"acquired":true,"shares":101365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders."}],"balance_after":101365,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":101365},"source":{"system":"sec-edgar","filing":"0000897069-23-001005","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706923001005/form4.xml","form_type":"4"}},{"id":1824038,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true}}],"security":"Restricted Stock","published_at":"2023-07-24T22:38:48.000Z","date":"2023-06-27","kind":"exercise","planned":false,"acquired":false,"shares":14407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting of time-based restricted shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Vesting of time-based restricted shares."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":14407},"source":{"system":"sec-edgar","filing":"0000897069-23-001005","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706923001005/form4.xml","form_type":"4"}},{"id":1824037,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-24T22:38:48.000Z","date":"2023-06-27","kind":"exercise","planned":false,"acquired":true,"shares":14407,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of time-based restricted shares."}],"balance_after":14407,"source":{"system":"sec-edgar","filing":"0000897069-23-001005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000089706923001005/form4.xml","form_type":"4"}},{"id":1857104,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2023-06-13T22:44:02.000Z","date":"2023-06-11","kind":"grant","planned":false,"acquired":true,"shares":12160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F5","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."}],"balance_after":12160,"derivative":{"exercise_price":1.6,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":12160},"source":{"system":"sec-edgar","filing":"0001493152-23-021130","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223021130/ownership.xml","form_type":"4"}},{"id":1857103,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-13T22:44:02.000Z","date":"2023-06-11","kind":"grant","planned":false,"acquired":true,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant."},{"field":"security","element":"securityTitle","label":"F3","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"N/A"}],"balance_after":5100,"derivative":{"underlying":"Common Stock","underlying_shares":5100},"source":{"system":"sec-edgar","filing":"0001493152-23-021130","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223021130/ownership.xml","form_type":"4"}},{"id":1907879,"issuer":{"id":85431,"kind":"organization","name":"Peak Bio, Inc.","symbol":"PKBO"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Notes","published_at":"2023-05-02T20:30:10.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"price":20004,"reported_value":20004,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Convertible Notes accrue interest at 6.0% per annum. At any time prior to maturity, the Reporting Person may convert the unpaid principal amount of the Convertible Notes, together with any accrued but unpaid interest, into shares of the Company's common stock at a price per share equal to $0.60. The Convertible Notes mature on October 28, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Convertible Notes accrue interest at 6.0% per annum. At any time prior to maturity, the Reporting Person may convert the unpaid principal amount of the Convertible Notes, together with any accrued but unpaid interest, into shares of the Company's common stock at a price per share equal to $0.60. The Convertible Notes mature on October 28, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The Convertible Notes accrue interest at 6.0% per annum. At any time prior to maturity, the Reporting Person may convert the unpaid principal amount of the Convertible Notes, together with any accrued but unpaid interest, into shares of the Company's common stock at a price per share equal to $0.60. The Convertible Notes mature on October 28, 2023."}],"derivative":{"expiration_date":"2023-10-28","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0000899243-23-011993","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600865/000089924323011993/doc4.xml","form_type":"4"}},{"id":1907878,"issuer":{"id":85431,"kind":"organization","name":"Peak Bio, Inc.","symbol":"PKBO"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Purchase)","published_at":"2023-05-02T20:30:10.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":33340,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The warrants were received in consideration for the loans forwarded by Mr. Neal and which are evidenced by the convertible promissory notes (the \"Convertible Notes\")."}],"balance_after":33340,"derivative":{"exercise_price":0.6,"exercise_date":"2023-04-28","expiration_date":"2028-04-28","underlying":"Common Stock","underlying_shares":33340},"source":{"system":"sec-edgar","filing":"0000899243-23-011993","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600865/000089924323011993/doc4.xml","form_type":"4"}},{"id":2203758,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2022-07-21T20:46:32.000Z","date":"2022-07-19","kind":"grant","acquired":true,"shares":17797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock vest on the earlier of one year from the grant date or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock vest on the earlier of one year from the grant date or the next annual meeting of stockholders."}],"balance_after":17797,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":17797},"source":{"system":"sec-edgar","filing":"0001567619-22-014305","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533743/000156761922014305/doc1.xml","form_type":"4"}},{"id":2206548,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-18T20:30:18.000Z","date":"2022-07-15","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to this option have fully vested as of February 10, 2020."}],"balance_after":218056,"derivative":{"exercise_price":4.03,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-22-008950","document":"marketforms-56649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922008950/marketforms-56649.xml","form_type":"4"}},{"id":2206547,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-07-18T20:30:18.000Z","date":"2022-07-15","kind":"sale","acquired":false,"shares":905,"price":31.861,"value":28834.205,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.53 to $32.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":11822,"source":{"system":"sec-edgar","filing":"0001214659-22-008950","document":"marketforms-56649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922008950/marketforms-56649.xml","form_type":"4"}},{"id":2206546,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-07-18T20:30:18.000Z","date":"2022-07-15","kind":"sale","acquired":false,"shares":3212,"price":31.1877,"value":100174.8924,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.53 to $31.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":12727,"source":{"system":"sec-edgar","filing":"0001214659-22-008950","document":"marketforms-56649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922008950/marketforms-56649.xml","form_type":"4"}},{"id":2206545,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-07-18T20:30:18.000Z","date":"2022-07-15","kind":"sale","acquired":false,"shares":20883,"price":29.5501,"value":617094.7383,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.25 to $30.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":15939,"source":{"system":"sec-edgar","filing":"0001214659-22-008950","document":"marketforms-56649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922008950/marketforms-56649.xml","form_type":"4"}},{"id":2206544,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-07-18T20:30:18.000Z","date":"2022-07-15","kind":"exercise","acquired":true,"shares":25000,"price":4.03,"value":100750.0,"ownership":{"direct":true},"balance_after":36822,"source":{"system":"sec-edgar","filing":"0001214659-22-008950","document":"marketforms-56649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922008950/marketforms-56649.xml","form_type":"4"}},{"id":2320678,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-23T22:52:28.000Z","date":"2022-03-23","kind":"exercise","acquired":false,"shares":1111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to this option have fully vested as of December 31, 2017."}],"balance_after":102800,"derivative":{"exercise_price":4.03,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":1111},"source":{"system":"sec-edgar","filing":"0001214659-22-004299","document":"marketforms-55844.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922004299/marketforms-55844.xml","form_type":"4"}},{"id":2320677,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-23T22:52:28.000Z","date":"2022-03-22","kind":"exercise","acquired":false,"shares":2339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to this option have fully vested as of December 31, 2017."}],"balance_after":103911,"derivative":{"exercise_price":4.03,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":2339},"source":{"system":"sec-edgar","filing":"0001214659-22-004299","document":"marketforms-55844.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922004299/marketforms-55844.xml","form_type":"4"}},{"id":2320676,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-23T22:52:28.000Z","date":"2022-03-21","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to this option have fully vested as of December 31, 2017."}],"balance_after":106250,"derivative":{"exercise_price":4.03,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-22-004299","document":"marketforms-55844.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922004299/marketforms-55844.xml","form_type":"4"}},{"id":2320675,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-03-23T22:52:28.000Z","date":"2022-03-23","kind":"sale","acquired":false,"shares":1111,"price":30.0164,"value":33348.2204,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.115, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":11822,"source":{"system":"sec-edgar","filing":"0001214659-22-004299","document":"marketforms-55844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922004299/marketforms-55844.xml","form_type":"4"}},{"id":2320674,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-03-23T22:52:28.000Z","date":"2022-03-23","kind":"exercise","acquired":true,"shares":1111,"price":4.03,"value":4477.33,"ownership":{"direct":true},"balance_after":12933,"source":{"system":"sec-edgar","filing":"0001214659-22-004299","document":"marketforms-55844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922004299/marketforms-55844.xml","form_type":"4"}},{"id":2320673,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-03-23T22:52:28.000Z","date":"2022-03-22","kind":"sale","acquired":false,"shares":2339,"price":30.0165,"value":70208.5935,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":11822,"source":{"system":"sec-edgar","filing":"0001214659-22-004299","document":"marketforms-55844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922004299/marketforms-55844.xml","form_type":"4"}},{"id":2320672,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-03-23T22:52:28.000Z","date":"2022-03-22","kind":"exercise","acquired":true,"shares":2339,"price":4.03,"value":9426.17,"ownership":{"direct":true},"balance_after":14161,"source":{"system":"sec-edgar","filing":"0001214659-22-004299","document":"marketforms-55844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922004299/marketforms-55844.xml","form_type":"4"}},{"id":2320671,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-03-23T22:52:28.000Z","date":"2022-03-21","kind":"sale","acquired":false,"shares":50000,"price":29.005,"value":1450250.0,"ownership":{"direct":true},"balance_after":11822,"source":{"system":"sec-edgar","filing":"0001214659-22-004299","document":"marketforms-55844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922004299/marketforms-55844.xml","form_type":"4"}},{"id":2320670,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-03-23T22:52:28.000Z","date":"2022-03-21","kind":"exercise","acquired":true,"shares":50000,"price":4.03,"value":201500.0,"ownership":{"direct":true},"balance_after":61822,"source":{"system":"sec-edgar","filing":"0001214659-22-004299","document":"marketforms-55844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465922004299/marketforms-55844.xml","form_type":"4"}},{"id":2404154,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-10T23:19:43.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":48340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period."}],"balance_after":48340,"derivative":{"exercise_price":2.32,"expiration_date":"2032-11-17","underlying":"Common Stock","underlying_shares":48340},"source":{"system":"sec-edgar","filing":"0001209191-22-008575","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000120919122008575/doc4.xml","form_type":"4"}},{"id":2460274,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Share Option (right to buy)","published_at":"2021-12-23T21:30:18.000Z","date":"2021-12-21","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this option shall vest in equal monthly installments over three years from the grant date."}],"balance_after":60000,"derivative":{"exercise_price":22.56,"expiration_date":"2031-12-21","underlying":"Common Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001214659-21-013606","document":"marketforms-54782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465921013606/marketforms-54782.xml","form_type":"4"}},{"id":2652729,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2021-06-29T21:09:26.000Z","date":"2021-06-25","kind":"sale","acquired":false,"shares":686,"price":35.1333,"value":24101.4438,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.78 to $35.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":11821.6,"source":{"system":"sec-edgar","filing":"0001214659-21-007038","document":"marketforms-53209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465921007038/marketforms-53209.xml","form_type":"4"}},{"id":2652728,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2021-06-29T21:09:26.000Z","date":"2021-06-25","kind":"sale","acquired":false,"shares":1171,"price":34.304,"value":40169.984,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.785 to $34.730, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":12507.6,"source":{"system":"sec-edgar","filing":"0001214659-21-007038","document":"marketforms-53209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465921007038/marketforms-53209.xml","form_type":"4"}},{"id":2652727,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2021-06-29T21:09:26.000Z","date":"2021-06-25","kind":"sale","acquired":false,"shares":7170.4,"price":33.3597,"value":239202.39288,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.77 to $33.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":13678.6,"source":{"system":"sec-edgar","filing":"0001214659-21-007038","document":"marketforms-53209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465921007038/marketforms-53209.xml","form_type":"4"}},{"id":2735739,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T21:54:14.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":4406,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Received in the Merger in exchange for a stock option to acquire 162,069 shares of LBS common stock for $0.73 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The stock option vests according to the following schedule: 25% of the shares underlying the option vests on the grant date and the remaining 75% vested in three equal quarterly installments thereafter beginning on September 30, 2020."}],"balance_after":4406,"derivative":{"exercise_price":26.85,"expiration_date":"2030-07-10","underlying":"Common Stock","underlying_shares":4406},"source":{"system":"sec-edgar","filing":"0001209191-21-029078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000120919121029078/doc4.xml","form_type":"4"}},{"id":2735738,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T21:54:14.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":1298,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Received in the Merger in exchange for a stock option to acquire 47,758 shares of LBS common stock for $1.12 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The stock option is fully vested."}],"balance_after":1298,"derivative":{"exercise_price":41.2,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":1298},"source":{"system":"sec-edgar","filing":"0001209191-21-029078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000120919121029078/doc4.xml","form_type":"4"}},{"id":2735737,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T21:54:14.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":5091,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Received in the Merger in exchange for a stock option to acquire 187,250 shares of LBS common stock for $1.12 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vested according to the following schedule: 25% of the shares underlying the option vested on the grant date and the remaining 75% vested in three equal quarterly installments thereafter beginning on June 30, 2019."}],"balance_after":5091,"derivative":{"exercise_price":41.2,"expiration_date":"2029-04-25","underlying":"Common Stock","underlying_shares":5091},"source":{"system":"sec-edgar","filing":"0001209191-21-029078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000120919121029078/doc4.xml","form_type":"4"}},{"id":2735736,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T21:54:14.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":1359,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in the Merger in exchange for a stock option to acquire 50,000 shares of LBS common stock for $1.45 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vested according to the following schedule: 50% of the shares underlying the option vested on the grant date and the remaining 50% vested in two equal quarterly installments thereafter beginning on September 30, 2018."}],"balance_after":1359,"derivative":{"exercise_price":53.33,"expiration_date":"2028-07-24","underlying":"Common Stock","underlying_shares":1359},"source":{"system":"sec-edgar","filing":"0001209191-21-029078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000120919121029078/doc4.xml","form_type":"4"}},{"id":2735735,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T21:54:14.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":3398,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in the Merger in exchange for a stock option to acquire 125,000 shares of LBS common stock for $1.45 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested according to the following schedule: 25% of the shares underlying the option vested on the grant date and the remaining 75% vested in three equal quarterly installments thereafter beginning on June 30, 2018."}],"balance_after":3398,"derivative":{"exercise_price":53.33,"expiration_date":"2028-04-05","underlying":"Common Stock","underlying_shares":3398},"source":{"system":"sec-edgar","filing":"0001209191-21-029078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000120919121029078/doc4.xml","form_type":"4"}},{"id":2735734,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T21:54:14.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":849,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in exchange for a stock option to acquire 31,250 shares of common stock of Leading BioSciences, Inc. (\"LBS\") for $0.75 per share, pursuant to the Agreement and Plan of Merger, dated December 16, 2020, among Seneca Biopharma Inc., Townsgate Acquisition Sub 1, Inc. and LBS (the \"Merger\").  Per the terms of the Merger, each share of LBS's common stock was converted into the right to receive 0.02719 shares of Seneca's common stock.  In the Merger, the name of the Issuer was changed from Seneca Biopharma, Inc. to Palisade Bio, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested in four equal quarterly installments from the vesting commencement date."}],"balance_after":849,"derivative":{"exercise_price":27.59,"expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":849},"source":{"system":"sec-edgar","filing":"0001209191-21-029078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000120919121029078/doc4.xml","form_type":"4"}},{"id":2750935,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Depositary Shares - 8.375% B Cumulative Stock","published_at":"2021-04-13T20:30:19.000Z","date":"2021-04-09","kind":"grant","acquired":true,"shares":8000,"price":25,"value":200000.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Purchased 8,000 depositary shares, each representing 1/1000 of a share of the Issuer's 8.375% Series B Cumulative Perpetual Preferred Stock (the \"Series B Preferred Stock\"), with liquidation preference of $25.00 per depositary share, in the Issuer's public offering at the public offering price of $25.00 per share. The terms of the Series B Preferred Stock are set\nforth in the Certificate of Designation of the 8.375% Series B Cumulative Perpetual Preferred Stock of the Issuer. Holders of the Series B Preferred Stock generally will have no voting rights, but will have limited voting rights if the Issuer fails to pay dividends for six or more quarters (whether or not declared or consecutive) and in certain other events."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001214659-21-004155","document":"marketforms-52234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465921004155/marketforms-52234.xml","form_type":"4"}},{"id":2847798,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Share Option (right to buy)","published_at":"2021-02-19T21:30:33.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":60268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this option shall vest in equal monthly installments over three years from the grant date."}],"balance_after":60268,"derivative":{"exercise_price":38.93,"expiration_date":"2031-02-17","underlying":"Common Shares","underlying_shares":60268},"source":{"system":"sec-edgar","filing":"0001214659-21-002126","document":"marketforms-51536.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465921002126/marketforms-51536.xml","form_type":"4"}},{"id":2941207,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-17T21:30:23.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to this option fully vested on February 21, 2017."}],"balance_after":0,"derivative":{"exercise_price":5.5,"expiration_date":"2017-12-22","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001214659-20-010509","document":"marketforms-50650.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920010509/marketforms-50650.xml","form_type":"4"}},{"id":2941206,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"8.625% Series A Cumulative Perpetual Preferred Stock","published_at":"2020-12-17T21:30:23.000Z","date":"2020-12-15","kind":"grant","acquired":true,"shares":8000,"price":25,"value":200000.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Purchased 8,000 shares of the Issuer's 8.625% Series A Cumulative Perpetual Preferred Stock, with liquidation preference of $25.00 per share (the \"Series A Preferred Stock\"), in the Issuer's public offering at the public offering price of $25.00 per share.  The terms of the Series A Preferred Stock are set forth in the Certificate of Designation of the 8.625% Series A Cumulative Perpetual Preferred Stock of the Issuer.  Holders of the Series A Preferred Stock generally will have no voting rights, but will have limited voting rights if the Issuer fails to pay dividends for six or more quarters (whether or not declared or consecutive) and in certain other events."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001214659-20-010509","document":"marketforms-50650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920010509/marketforms-50650.xml","form_type":"4"}},{"id":2941205,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-12-17T21:30:23.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":5706,"price":42.0435,"value":239900.211,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.98 to $42.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20849,"source":{"system":"sec-edgar","filing":"0001214659-20-010509","document":"marketforms-50650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920010509/marketforms-50650.xml","form_type":"4"}},{"id":2941204,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-12-17T21:30:23.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":20294,"price":41.15,"value":835098.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.9650 to $41.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":26555,"source":{"system":"sec-edgar","filing":"0001214659-20-010509","document":"marketforms-50650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920010509/marketforms-50650.xml","form_type":"4"}},{"id":2941203,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-12-17T21:30:23.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":26000,"price":5.5,"value":143000.0,"ownership":{"direct":true},"balance_after":46849,"source":{"system":"sec-edgar","filing":"0001214659-20-010509","document":"marketforms-50650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920010509/marketforms-50650.xml","form_type":"4"}},{"id":2969045,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-24T21:30:17.000Z","date":"2020-11-23","kind":"exercise","acquired":false,"shares":13126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to this option fully vested on February 21, 2017."}],"balance_after":26000,"derivative":{"exercise_price":5.5,"expiration_date":"2026-12-22","underlying":"Common Stock","underlying_shares":13126},"source":{"system":"sec-edgar","filing":"0001214659-20-009865","document":"marketforms-50231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920009865/marketforms-50231.xml","form_type":"4"}},{"id":2969044,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-24T21:30:17.000Z","date":"2020-11-20","kind":"exercise","acquired":false,"shares":6874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to this option fully vested on February 21, 2017."}],"balance_after":39126,"derivative":{"exercise_price":5.5,"expiration_date":"2026-12-22","underlying":"Common Stock","underlying_shares":6874},"source":{"system":"sec-edgar","filing":"0001214659-20-009865","document":"marketforms-50231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920009865/marketforms-50231.xml","form_type":"4"}},{"id":2969043,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-11-24T21:30:17.000Z","date":"2020-11-23","kind":"sale","acquired":false,"shares":13126,"price":32.9622,"value":432661.8372,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.25 to $33.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20849,"source":{"system":"sec-edgar","filing":"0001214659-20-009865","document":"marketforms-50231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920009865/marketforms-50231.xml","form_type":"4"}},{"id":2969042,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-11-24T21:30:17.000Z","date":"2020-11-23","kind":"exercise","acquired":true,"shares":13126,"price":5.5,"value":72193.0,"ownership":{"direct":true},"balance_after":33975,"source":{"system":"sec-edgar","filing":"0001214659-20-009865","document":"marketforms-50231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920009865/marketforms-50231.xml","form_type":"4"}},{"id":2969041,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-11-24T21:30:17.000Z","date":"2020-11-20","kind":"sale","acquired":false,"shares":426,"price":33.3513,"value":14207.6538,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.24 to $34.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20849,"source":{"system":"sec-edgar","filing":"0001214659-20-009865","document":"marketforms-50231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920009865/marketforms-50231.xml","form_type":"4"}},{"id":2969040,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-11-24T21:30:17.000Z","date":"2020-11-20","kind":"sale","acquired":false,"shares":6448,"price":32.462,"value":209314.976,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21275,"source":{"system":"sec-edgar","filing":"0001214659-20-009865","document":"marketforms-50231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920009865/marketforms-50231.xml","form_type":"4"}},{"id":2969039,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-11-24T21:30:17.000Z","date":"2020-11-20","kind":"exercise","acquired":true,"shares":6874,"price":5.5,"value":37807.0,"ownership":{"direct":true},"balance_after":27723,"source":{"system":"sec-edgar","filing":"0001214659-20-009865","document":"marketforms-50231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920009865/marketforms-50231.xml","form_type":"4"}},{"id":2990553,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T22:20:15.000Z","date":"2020-11-05","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to this option fully vested on February 21, 2017."}],"balance_after":46000,"derivative":{"exercise_price":5.5,"expiration_date":"2026-12-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001214659-20-009223","document":"marketforms-49968.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920009223/marketforms-49968.xml","form_type":"4"}},{"id":2990552,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-11-06T22:20:15.000Z","date":"2020-11-05","kind":"sale","acquired":false,"shares":727,"price":27.5,"value":19992.5,"ownership":{"direct":true},"balance_after":20849,"source":{"system":"sec-edgar","filing":"0001214659-20-009223","document":"marketforms-49968.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920009223/marketforms-49968.xml","form_type":"4"}},{"id":2990551,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-11-06T22:20:15.000Z","date":"2020-11-05","kind":"sale","acquired":false,"shares":9273,"price":25.9045,"value":240212.4285,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.6050 to $26.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21576,"source":{"system":"sec-edgar","filing":"0001214659-20-009223","document":"marketforms-49968.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920009223/marketforms-49968.xml","form_type":"4"}},{"id":2990550,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-11-06T22:20:15.000Z","date":"2020-11-05","kind":"exercise","acquired":true,"shares":10000,"price":5.5,"value":55000.0,"ownership":{"direct":true},"balance_after":30849,"source":{"system":"sec-edgar","filing":"0001214659-20-009223","document":"marketforms-49968.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920009223/marketforms-49968.xml","form_type":"4"}},{"id":3197238,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2020-03-24T20:38:25.000Z","date":"2020-03-23","kind":"purchase","acquired":true,"shares":1000,"price":14.5,"value":14500.0,"ownership":{"direct":true},"balance_after":20849,"source":{"system":"sec-edgar","filing":"0001214659-20-002883","document":"marketforms-48432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920002883/marketforms-48432.xml","form_type":"4"}},{"id":3198548,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2020-03-23T20:30:13.000Z","date":"2020-03-20","kind":"purchase","acquired":true,"shares":1000,"price":16.41,"value":16410.0,"ownership":{"direct":true},"balance_after":19849,"source":{"system":"sec-edgar","filing":"0001214659-20-002831","document":"marketforms-48401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920002831/marketforms-48401.xml","form_type":"4"}},{"id":3209882,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2020-03-16T20:30:23.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":66200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to this option shall vest in equal monthly installments over three years from the grant date."}],"balance_after":66200,"derivative":{"exercise_price":18.84,"expiration_date":"2030-03-13","underlying":"Common Shares","underlying_shares":66200},"source":{"system":"sec-edgar","filing":"0001214659-20-002654","document":"marketforms-48330.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920002654/marketforms-48330.xml","form_type":"4"}},{"id":3310175,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Subscription Rights (right to buy)","published_at":"2020-01-16T22:33:48.000Z","date":"2019-12-23","kind":"other","acquired":false,"shares":1180,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":22,"exercise_date":"2019-12-02","expiration_date":"2019-12-18","underlying":"Common Stock","underlying_shares":1180},"source":{"system":"sec-edgar","filing":"0001214659-20-000414","document":"marketforms-47459.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920000414/marketforms-47459.xml","form_type":"4"}},{"id":3310174,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Shares","published_at":"2020-01-16T22:33:48.000Z","date":"2019-12-23","kind":"other","acquired":true,"shares":1180,"price":22,"value":25960.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person exercised in full his subscription rights (each subscription right entitling it to purchase 0.067 shares of XOMA Corporation (\"XOMA\") common stock, at a subscription price equal to $22.00 per share), issued pro rata to holders of XOMA common stock on the record date for the rights offering. The reporting person acquired these shares of common stock at the closing of the rights offering."}],"balance_after":18849,"source":{"system":"sec-edgar","filing":"0001214659-20-000414","document":"marketforms-47459.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465920000414/marketforms-47459.xml","form_type":"4"}},{"id":3377009,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-08T21:30:18.000Z","date":"2019-11-06","kind":"exercise","acquired":false,"shares":4348,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":56000,"derivative":{"exercise_price":5.5,"exercise_date":"2017-12-21","expiration_date":"2026-12-22","underlying":"Common Stock","underlying_shares":4348},"source":{"system":"sec-edgar","filing":"0001214659-19-006961","document":"marketforms-46066.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465919006961/marketforms-46066.xml","form_type":"4"}},{"id":3377008,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-11-08T21:30:18.000Z","date":"2019-11-06","kind":"sale","acquired":false,"shares":4348,"price":22,"value":95656.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":17669,"source":{"system":"sec-edgar","filing":"0001214659-19-006961","document":"marketforms-46066.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465919006961/marketforms-46066.xml","form_type":"4"}},{"id":3377007,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-11-08T21:30:18.000Z","date":"2019-11-06","kind":"exercise","acquired":true,"shares":4348,"price":5.5,"value":23914.0,"ownership":{"direct":true},"balance_after":22017,"source":{"system":"sec-edgar","filing":"0001214659-19-006961","document":"marketforms-46066.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/791908/000121465919006961/marketforms-46066.xml","form_type":"4"}},{"id":3409392,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-20T23:40:41.000Z","date":"2019-09-20","kind":"exercise","acquired":false,"shares":5452,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60348,"derivative":{"exercise_price":5.5,"exercise_date":"2017-12-21","expiration_date":"2026-12-22","underlying":"Common Stock","underlying_shares":5452},"source":{"system":"sec-edgar","filing":"0001209191-19-050393","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/791908/000120919119050393/doc4.xml","form_type":"4"}},{"id":3409391,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-20T23:40:41.000Z","date":"2019-09-19","kind":"exercise","acquired":false,"shares":6370,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":65800,"derivative":{"exercise_price":5.5,"exercise_date":"2017-12-21","expiration_date":"2026-12-22","underlying":"Common Stock","underlying_shares":6370},"source":{"system":"sec-edgar","filing":"0001209191-19-050393","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/791908/000120919119050393/doc4.xml","form_type":"4"}},{"id":3409390,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-20T23:40:41.000Z","date":"2019-09-18","kind":"exercise","acquired":false,"shares":3830,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":72170,"derivative":{"exercise_price":5.5,"exercise_date":"2017-12-21","expiration_date":"2026-12-22","underlying":"Common Stock","underlying_shares":3830},"source":{"system":"sec-edgar","filing":"0001209191-19-050393","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/791908/000120919119050393/doc4.xml","form_type":"4"}},{"id":3409389,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-09-20T23:40:41.000Z","date":"2019-09-20","kind":"sale","acquired":false,"shares":5452,"price":20.2257,"value":110270.5164,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.7150, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range"}],"balance_after":17669,"source":{"system":"sec-edgar","filing":"0001209191-19-050393","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/791908/000120919119050393/doc4.xml","form_type":"4"}},{"id":3409388,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-09-20T23:40:41.000Z","date":"2019-09-20","kind":"exercise","acquired":true,"shares":5452,"price":5.5,"value":29986.0,"ownership":{"direct":true},"balance_after":23121,"source":{"system":"sec-edgar","filing":"0001209191-19-050393","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/791908/000120919119050393/doc4.xml","form_type":"4"}},{"id":3409387,"issuer":{"id":30207,"kind":"organization","name":"XOMA Royalty Corp","symbol":"XOMA"},"owners":[{"id":28198,"kind":"person","name":"Neal James R","position":1,"cik":"0001600865","reported_name":"Neal James R","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-09-20T23:40:41.000Z","date":"2019-09-19","kind":"sale","acquired":false,"shares":2642,"price":21.7317,"value":57415.1514,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.6350 to $21.9750, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":17669,"source":{"system":"sec-edgar","filing":"0001209191-19-050393","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/791908/000120919119050393/doc4.xml","form_type":"4"}}],"next_cursor":"2019-09-20T23:40:41.000000Z,3409387"}